We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » European Commission Approves Sandoz's Omnitrope
European Commission Approves Sandoz's Omnitrope
April 21, 2006
The European Commission (EC) has granted Sandoz marketing authorization for its recombinant human growth hormone Omnitrope that will be the first biosimilar to be marketed after being approved under the EC’s biosimilar pathway.